
        <!DOCTYPE html>
        <html>
        <head>
            <title>Immunocore Holdings plc (IMCR) - Articles</title>
            <meta name="viewport" content="width=device-width, initial-scale=1.0">
            <style>
                :root {
                    --primary-color: #000000;
                    --secondary-color: #666666;
                    --accent-color: #d5001c;
                    --text-color: #2c3e50;
                    --border-color: #e0e0e0;
                    --hover-color: #f8f9fa;
                }
                
                body { 
                    font-family: "Porsche Next", "Segoe UI", Arial, sans-serif;
                    margin: 0;
                    padding: 0;
                    color: var(--text-color);
                    background-color: #f5f6fa;
                    line-height: 1.6;
                }
                
                .header {
                    background: linear-gradient(135deg, #000 0%, #1a1a1a 100%);
                    padding: 25px 0;
                    box-shadow: 0 2px 10px rgba(0,0,0,0.2);
                    position: sticky;
                    top: 0;
                    z-index: 1000;
                    backdrop-filter: blur(10px);
                }
                
                .header::before {
                    content: '';
                    position: absolute;
                    top: 0;
                    left: 0;
                    right: 0;
                    bottom: 0;
                    background: radial-gradient(circle at 30% 50%, rgba(255,255,255,0.08) 0%, rgba(255,255,255,0) 70%);
                    pointer-events: none;
                }
                
                .header-content {
                    max-width: 1400px;
                    margin: 0 auto;
                    padding: 0 30px;
                    display: flex;
                    justify-content: space-between;
                    align-items: center;
                }
                
                .header-title {
                    font-size: 28px;
                    font-weight: 300;
                    color: #fff;
                    margin: 0;
                    letter-spacing: 1px;
                }
                
                .back-btn {
                    background: rgba(255,255,255,0.1);
                    border: 1px solid rgba(255,255,255,0.2);
                    padding: 10px 20px;
                    color: #fff;
                    text-decoration: none;
                    font-size: 14px;
                    border-radius: 4px;
                    transition: all 0.3s ease;
                    backdrop-filter: blur(5px);
                }
                
                .back-btn:hover {
                    background: rgba(255,255,255,0.2);
                    transform: translateY(-2px);
                }
                
                .container {
                    max-width: 1400px;
                    margin: 40px auto;
                    padding: 0 30px;
                }
                
                .stats-container {
                    display: grid;
                    grid-template-columns: repeat(auto-fit, minmax(250px, 1fr));
                    gap: 20px;
                    margin-bottom: 40px;
                }
                
                .stat-card {
                    background: #fff;
                    border-radius: 12px;
                    padding: 25px;
                    text-align: center;
                    box-shadow: 0 4px 20px rgba(0,0,0,0.08);
                    transition: transform 0.3s ease;
                }
                
                .stat-card:hover {
                    transform: translateY(-5px);
                }
                
                .stat-value {
                    font-size: 32px;
                    font-weight: 300;
                    color: var(--primary-color);
                    margin-bottom: 10px;
                }
                
                .stat-label {
                    font-size: 14px;
                    color: var(--secondary-color);
                    text-transform: uppercase;
                    letter-spacing: 1px;
                }
                
                .articles-grid {
                    display: grid;
                    grid-template-columns: repeat(auto-fill, minmax(400px, 1fr));
                    gap: 30px;
                    margin-top: 40px;
                }
                
                .article-card {
                    background: #fff;
                    border-radius: 12px;
                    overflow: hidden;
                    box-shadow: 0 4px 20px rgba(0,0,0,0.08);
                    transition: all 0.3s ease;
                }
                
                .article-card:hover {
                    transform: translateY(-5px);
                }
                
                .article-content {
                    padding: 25px;
                }
                
                .article-title {
                    font-size: 18px;
                    font-weight: 400;
                    margin: 0 0 15px;
                    line-height: 1.4;
                }
                
                .article-title a {
                    color: var(--primary-color);
                    text-decoration: none;
                    transition: color 0.2s ease;
                }
                
                .article-title a:hover {
                    color: var(--accent-color);
                }
                
                .article-meta {
                    display: flex;
                    align-items: center;
                    gap: 20px;
                    margin-bottom: 15px;
                    font-size: 14px;
                    color: var(--secondary-color);
                }
                
                .article-sentiment {
                    padding: 4px 12px;
                    border-radius: 20px;
                    font-weight: 500;
                    font-size: 14px;
                }
                
                .article-sentiment.positive {
                    background: rgba(40,167,69,0.1);
                    color: #28a745;
                }
                
                .article-sentiment.negative {
                    background: rgba(220,53,69,0.1);
                    color: #dc3545;
                }
                
                .article-sentiment.neutral {
                    background: rgba(108,117,125,0.1);
                    color: #6c757d;
                }
                
                .article-summary {
                    font-size: 14px;
                    color: var(--text-color);
                    line-height: 1.6;
                    margin-top: 15px;
                    opacity: 0.8;
                }
                
                @media (max-width: 768px) {
                    .header-content {
                        padding: 0 20px;
                    }
                    
                    .header-title {
                        font-size: 20px;
                    }
                    
                    .container {
                        padding: 0 20px;
                        margin: 20px auto;
                    }
                    
                    .articles-grid {
                        grid-template-columns: 1fr;
                        gap: 20px;
                    }
                    
                    .stat-card {
                        padding: 20px;
                    }
                    
                    .stat-value {
                        font-size: 28px;
                    }
                }
            </style>
        </head>
        <body>
            <div class="header">
                <div class="header-content">
                    <h1 class="header-title">Immunocore Holdings plc (IMCR)</h1>
                    <a href="sentiment_report_latest.html" class="back-btn">‚Üê Back to Dashboard</a>
                </div>
            </div>
            
            <div class="container">
                <div class="stats-container">
                    <div class="stat-card">
                        <div class="stat-value">28</div>
                        <div class="stat-label">Total Articles</div>
                    </div>
                    <div class="stat-card">
                        <div class="stat-value">12</div>
                        <div class="stat-label">Positive Articles</div>
                    </div>
                    <div class="stat-card">
                        <div class="stat-value">9</div>
                        <div class="stat-label">Negative Articles</div>
                    </div>
                    <div class="stat-card">
                        <div class="stat-value">0.11</div>
                        <div class="stat-label">Average Sentiment</div>
                    </div>
                </div>
                
                <div class="articles-grid">
        
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=0255d1acc7f1a0d08356794a45b1ef705cdbd12b61a90e9bc55a1163e004823f" target="_blank" rel="noopener noreferrer">Immunocore Holdings plc (IMCR) Q2 2025 Earnings Call Transcript</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-09</span>
                                <span>SeekingAlpha</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">Immunocore Holdings plc (NASDAQ:IMCR) Q2 2025 Earnings Conference Call August 7, 2025 8:00 AM ETCompany Participants&amp; - Corporate ParticipantBahija......</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=90ce7b62313e75620d783820927b836154090c3cbb17bf6f01a32284b95347cf" target="_blank" rel="noopener noreferrer">Immunocore Holdings plc 2025 Q2 - Results - Earnings Call Presentation</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-09</span>
                                <span>SeekingAlpha</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">The following slide deck was published by Immunocore Holdings plc in conjunction with their 2025 Q2 earnings call....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=7646b18b9dcc7543837e6de69271c46ab97f73ce3e420602ef9b972628faa1f9" target="_blank" rel="noopener noreferrer">PBYI's Q2 Earnings Beat Estimates, Nerlynx Sales Drive Revenues</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-08</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.95
                                </span>
                            </div>
                            <div class="article-summary">Puma Biotechnology tops second-quarter earnings and revenue estimates as rising Nerlynx sales drive growth....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=79f013a131ee1e7e6976685e2e7fb9f98849ec873b6187b7b638209ae55fef5c" target="_blank" rel="noopener noreferrer">Immunocore Holdings PLC (IMCR) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and ...</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-08</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.95
                                </span>
                            </div>
                            <div class="article-summary">Immunocore Holdings PLC (IMCR) reports robust KimTrac sales and global expansion, while navigating challenges in clinical trials and regulatory landscapes....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=a43a37cd0dcbd36152114259bd1ec98a3f75b3bc8b425fb159f6dabfbce7a1e8" target="_blank" rel="noopener noreferrer">Intellia Q2 Loss Narrower Than Expected, Pipeline Progress in Focus</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-08</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.60
                                </span>
                            </div>
                            <div class="article-summary">NTLA posts narrower Q2 loss and beats on revenues, while advancing phase III studies for ATTR and HAE programs....</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=1ffb56f0fb9830ca02b2f4aa12216da5aa7731586640da45c4502693a45bf7dd" target="_blank" rel="noopener noreferrer">IOVA Q2 Earnings Miss, Stock Down on EMA Filing Withdrawal for Amtagvi</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-08</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment negative">
                                    -0.97
                                </span>
                            </div>
                            <div class="article-summary">Iovance shares plunge after Q2 miss and voluntary withdrawal of Amtagvi's EU filing, despite strong U.S. sales growth for the therapy....</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=66d2789f62937c267ac9eaaed9af69d8966ffa0fb6d5ae59ecc6175a04c0cbe7" target="_blank" rel="noopener noreferrer">Immunocore reports second quarter financial results and provides a business update</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-07</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">KIMMTRAK¬Æ (tebentafusp-tebn) net revenues of $98.0 million in Q2 2025, growing by 30% year-over-year Phase 3 TEBE-AM trial on track to complete enrollment in 1H 2026 Dose selection for PRISM-MEL-301 P...</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=171203279452d244bf672ac99532cf156208aec2f762559e2698cc9586b4178e" target="_blank" rel="noopener noreferrer">ADMA Beats on Q2 Earnings and Revenues, Asceniv Drives Momentum</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-07</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment negative">
                                    -0.21
                                </span>
                            </div>
                            <div class="article-summary">ADMA Biologics' Q2 earnings and revenue beat can be attributed to Asceniv growth. However, shares fall 7.4% in after-hours trading....</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=6845f0b1794da81f4569311ac2e36303911872eadf79d3dace2aea9012c0c760" target="_blank" rel="noopener noreferrer">Compared to Estimates, Immunocore (IMCR) Q2 Earnings: A Look at Key Metrics</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-07</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">While the top- and bottom-line numbers for Immunocore (IMCR) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=9d86d54b4423f60c83798bd5e3eda596f2d29672cac26ea4f19eaa8b33fcaeb8" target="_blank" rel="noopener noreferrer">Acadia Q2 Earnings Beat, Nuplazid & Daybue Sales Drive Revenue Growth</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-07</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.96
                                </span>
                            </div>
                            <div class="article-summary">ACAD reports encouraging second-quarter results as earnings and revenues beat estimates, driven by year-over-year growth in Nuplazid and Daybue sales....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=28dcff8690461dd485b5a77edc89f00cdcb30bf82da42cacc50842e21dc5d82f" target="_blank" rel="noopener noreferrer">Catalyst Pharmaceuticals Q2 Earnings Beat, Firdapse Revenues Rise Y/Y</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-07</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.95
                                </span>
                            </div>
                            <div class="article-summary">CPRX beats Q2 earnings and revenue estimates as Firdapse and Agamree drive strong top-line growth....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=326c8620d7f99382abc6cdb7eb461cbccc388f9e58eca177192ab5ce80c75d92" target="_blank" rel="noopener noreferrer">MIRM Stock Up on Q2 Earnings and Revenue Beat, Raised 2025 View</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-07</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.95
                                </span>
                            </div>
                            <div class="article-summary">Mirum surges after second-quarter earnings and revenues top estimates, driven by Livmarli growth and a raised 2025 outlook....</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=c1f87a9d417aeaccb4b19cc56731aab35fe3fca6f5902d4ec38b7967c4d67bb0" target="_blank" rel="noopener noreferrer">JAZZ Stock Down on Wider-Than-Expected Q2 Loss, '25 Sales View Cut</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-06</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment negative">
                                    -0.97
                                </span>
                            </div>
                            <div class="article-summary">Jazz shares slide as Q2 loss widens on Chimerix charge, with 2025 sales outlook trimmed despite higher EPS guidance....</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=9bca47a130df8386ccce27fa0fdca30c4f11dd2259cb21e6cae68ccc08958594" target="_blank" rel="noopener noreferrer">ESPR's Q2 Earnings & Revenues Trump Estimates, Stock Rises</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-06</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment negative">
                                    -0.56
                                </span>
                            </div>
                            <div class="article-summary">Esperion posts narrower-than-expected second-quarter loss with revenues rising 12% and product sales jumping 42% year over year....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=7617ebe77f199aa474496bd605028449a8c26e9f1a9acc352366272efc9da4d0" target="_blank" rel="noopener noreferrer">Ultragenyx's Q2 Loss Narrower Than Expected, Revenues Rise Y/Y</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-06</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.77
                                </span>
                            </div>
                            <div class="article-summary">RARE posts a narrower Q2 loss and 13% revenue growth as demand rises across all four marketed rare disease drugs....</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=58f8c91b8a1f3b15fc7278da01200b51117cf393bdbb83e775759cbea39bd810" target="_blank" rel="noopener noreferrer">RXRX Q2 Loss Wider Than Expected, Revenues Rise Y/Y, Stock Down</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-06</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment negative">
                                    -0.29
                                </span>
                            </div>
                            <div class="article-summary">Recursion Pharmaceuticals stock drops as Q2 loss widens and pipeline shake-up continues, despite revenues boost from Sanofi milestone....</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=22f3d1db6ae0c2c05e6f6b992bfafa46159f99bfb8e3de034d9b805105037f0d" target="_blank" rel="noopener noreferrer">BEAM's Q2 Loss Narrower Than Expected, Revenues Miss Mark</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-06</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment negative">
                                    -0.95
                                </span>
                            </div>
                            <div class="article-summary">Beam Therapeutics posts narrower second-quarter loss but misses revenue estimates. The company provides updates on pipeline progress....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=46f6902e8afb10108a8ac0e3762d8873eb3fbf7ca1fce4802341c319a6c00bd3" target="_blank" rel="noopener noreferrer">BioMarin Beats on Q2 Earnings & Sales, Stock Gains on Raised '25 View</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-05</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.92
                                </span>
                            </div>
                            <div class="article-summary">BMRN's Q2 earnings surge 50% on strong Voxzogo and enzyme therapy sales, prompting a raised 2025 revenue and EPS outlook....</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=463f9c55291b9a7645313e4bdbb413801cefee4de694a61fb50df72911783f14" target="_blank" rel="noopener noreferrer">VRTX Q2 Earnings Beat, Stock Down as Pain Drug Misses Study Goal</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-05</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment negative">
                                    -0.96
                                </span>
                            </div>
                            <div class="article-summary">Vertex beats second-quarter earnings and revenue estimates, but shares slide as pain drug VX-993 misses study goal....</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=924a6eb23e4c280bfde275b3fc1b6bd81d50e9588138c7b8c6af3762748d92de" target="_blank" rel="noopener noreferrer">AXSM Q2 Loss Narrower Than Expected, Auvelity Drives Revenues Y/Y</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-05</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment neutral">
                                    -0.11
                                </span>
                            </div>
                            <div class="article-summary">Axsome posts narrower second-quarter loss and 72% revenue surge, driven by strong Auvelity sales....</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=a106fd3da090e07853514caad212a7a55146a0b04c7a2a6e4d9a94e4fadb629c" target="_blank" rel="noopener noreferrer">CRSP Stock Down on Huge Q2 Loss, Focus on Increasing Casgevy Adoption</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-05</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment negative">
                                    -0.93
                                </span>
                            </div>
                            <div class="article-summary">CRISPR Therapeutics posts a wider second-quarter loss tied to Sirius deal costs, while Casgevy adoption gains momentum across global markets....</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=0e7e6f6f9c374aa38fe958e3b6ff9bbafb87437dfad574eafacc9a5ba629d077" target="_blank" rel="noopener noreferrer">TGTX Down as Q2 Earnings Miss Mark, Briumvi Sales Drive Top Line</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-05</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment negative">
                                    -0.96
                                </span>
                            </div>
                            <div class="article-summary">TG Therapeutics slides 18% as second-quarter earnings fall short despite a 92% revenue jump fueled by surging Briumvi sales....</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=7b95d7d7a4697d233757208ffc06aff6cc1368df11f6b4ccaeebc440675b77cd" target="_blank" rel="noopener noreferrer">FOLD Q2 Earnings Miss Mark, Revenues Beat on Higher Product Sales</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-08-01</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment neutral">
                                    -0.11
                                </span>
                            </div>
                            <div class="article-summary">Amicus misses second-quarter earnings estimates but beats the same for revenues, driven by strong sales of Galafold and Pombiliti + Opfolda....</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=b0e522a4a0b3657a5eb9ec4df5467819be688479532758302e73caa225ae2c8b" target="_blank" rel="noopener noreferrer">Immunocore to report second quarter 2025 financial results and host call on August 7, 2025</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-07-31</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">(OXFORDSHIRE, England & CONSHOHOCKEN, Penn. & GAITHERSBURG, Md., US, July 31, 2025) Immunocore Holdings plc (Nasdaq: IMCR) (‚ÄúImmunocore‚Äù or the ‚ÄúCompany‚Äù), a commercial-stage biotechnology company pio...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=036b08e9194ca0ce595a857255bc685bc82eadd608d927257a240f4aa13d626e" target="_blank" rel="noopener noreferrer">UTHR Q2 Earnings Miss Estimates, Higher Tyvaso Sales Aid Revenues Y/Y</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-07-31</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.87
                                </span>
                            </div>
                            <div class="article-summary">United Therapeutics' second-quarter earnings miss estimates, while revenues rise 12% on strong Tyvaso and other product sales....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=f9f411539c331ccbde19a5195dbcd83901bdedf5a87ef97d65cd83d5272c2781" target="_blank" rel="noopener noreferrer">Amarin's Q2 Earnings & Revenues Trump Estimates, Stock Rises</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-07-31</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.57
                                </span>
                            </div>
                            <div class="article-summary">AMRN beats second-quarter estimates for earnings. Revenues rise year over year on strong licensing gains....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=f630409e306d5775718b3fbac9d3861858edbeca5a36302fdfd8cfd7dd3fd8bf" target="_blank" rel="noopener noreferrer">Alkermes Q2 Earnings Beat Estimates, Proprietary Drugs Aid Sales</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-07-30</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.84
                                </span>
                            </div>
                            <div class="article-summary">ALKS beats second-quarter estimates as proprietary product sales rise 14% y/y, offsetting weaker manufacturing and royalty revenues....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=e5bcd832e193987e1195fe3f4f94f0ed54f723122b82babf1ceb91fd938ce93f" target="_blank" rel="noopener noreferrer">Wall Street Analysts See a 72.34% Upside in Immunocore (IMCR): Can the Stock Really Move This High?</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-07-24</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.70
                                </span>
                            </div>
                            <div class="article-summary">The consensus price target hints at a 72.3% upside potential for Immunocore (IMCR). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estima...</div>
                        </div>
                    </div>
            
                </div>
            </div>
        </body>
        </html>
        